Transaction · 0001649094-25-000010

Wassil Jim

Wassil Jim, COO, reported a transaction classified as exercise at Vaxcyte, Inc. involving 8000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 2638.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCOO
PCVXVaxcyte, Inc.
Filing timeFeb 05
Trade dateFeb 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

PCVX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PCVX since 2025-02-05Filed 576 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001649094-25-000010
Stock Option (right to buy)
Transaction date
Feb 03, 2025
Filed Feb 05, 2025, 12:20 AM · 2d delay
Shares
8.00k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
2.63k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF OPERATING OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024.

  2. F2

    The price reported is a weighted-average price. The shares were sold at prices ranging from $85.32 to $86.295. The reporting person will provide upon request to the SEC, the issuer or security holder…

  3. (2 footnotes)

    issuer, full information regarding the number of shares sold at each separate price.

  4. F3

    The price reported is a weighted-average price. The shares were sold at prices ranging from $86.365 to $87.10. The reporting person will provide upon request to the SEC, the issuer or security holder…

  5. F4

    Option is fully vested and exercisable.

Original filing · 0001649094-25-000010
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PCVX